Background/Aims: This study aimed to verify if odor cues released by Ehrlich tumor-bearing mice are aversive and stressful. Methods: Female mice were divided into a control group and an experimental group. One animal of each experimental pair of mice was inoculated with 5 × 106 Ehrlich tumor cells intraperitoneally; the other animal was kept undisturbed and was referred to as a CSP (companion of sick partner). One mouse of each control pair was treated intraperitoneally with 0.9% NaCl (1 mg/kg); the other animal (CHP, companion of healthy partner) was kept undisturbed. Results: It was shown that, in relation to CHP, CSP mice (1) spent less time within the companion zone in a T-maze place preference test, (2) had increased levels of social interaction, (3) had increased levels of plasmatic adrenaline and noradrenaline and (4) displayed no changes in serum corticosterone levels before and after an immobilization stress challenge. It was also shown that (5) cohabitation with 2 tumor-bearing mice was more effective in decreasing neutrophil oxidative burst than cohabitation with 1 sick partner and (6) the presence of a healthy conspecific within the cage of the tumor-injected/CSP pair abrogated the effects of cohabitation on neutrophil activity. These results show that odor cues released by Ehrlich tumor-injected mice are aversive and induce psychological stress. Conclusion: We postulate that the aversive response induced by the chemosignals released by Ehrlich tumor-injected animals activates the sympathetic nervous system and causes the neuroimmunal changes that occur in the mice cohabiting with the sick mice.

1.
Doty RL: Odor-guided behavior in mammals. Experientia 1986;42:257-271.
2.
Kaidanovich-Beilin O, Lipina T, Vukobradovic I, Roder J, Woodgett JR: Assessment of social interaction behaviors. J Vis Exp 2011, DOI: 10.3791/2473.
3.
Arakawa H, Cruz S, Deak T: Attractiveness of illness-associated odorant cues in female rats is modulated by ovarian hormones, but not associated with pro-inflammatory cytokine levels. Brain Behav Immun 2012;26:40-49.
4.
Matsumura K, Opiekun M, Oka H, Vachani A, Albelda SM, Yamazaki K, Beauchamp GK: Urinary volatile compounds as biomarkers for lung cancer: a proof of principle study using odor signatures in mouse models of lung cancer. PLoS One 2010;27;5:e8819.
5.
Kavaliers M, Colwell DD, Choleris E, Agmo A, Muglia LJ, Ogawa S, Pfaff DW: Impaired discrimination of and aversion to parasitized male odors by female oxytocin knockout mice. Genes Brain Behav 2003;2:220-230.
6.
Penn D, Potts WK: Chemical signals and parasite-mediated sexual selection. Trends Ecol Evol 1998;13:391-396.
7.
Morgulis MS, Stankevicius D, Sá-Rocha LC, Palermo-Neto J: Cohabitation with a sick cage mate: consequences on behavior and on Ehrlich tumor growth. Neuroimmunomodulation 2004;11:49-57.
8.
Alves GJ, Vismari L, Florio JC, Palermo-Neto J: Cohabitation with a sick cage mate: effects on noradrenaline turnover and neutrophil activity. Neurosci Res 2006;56:172-179.
9.
Alves GJ, Vismari L, Palermo-Neto J: Cohabitation with a sick cage mate: effects on ascitic form of Ehrlich tumor growth and macrophage activity. Neuroimmunomodulation 2007;14:297-303.
10.
Tomiyoshi MY, Sakai M, Baleeiro RB, Stankevicius D, Massoco CO, Palermo-Neto J, Barbuto JA: Cohabitation with a B16F10 melanoma-bearer cage mate influences behavior and dendritic cell phenotype in mice. Brain Behav Immun 2009;23:558-567.
11.
Alves GJ, Ribeiro A, Palermo-Neto J: The neuroimmune changes induced by cohabitation with an Ehrlich tumor-bearing cage mate rely on olfactory information. Brain Behav Immun 2012;26:32-39.
12.
Hughes NK, Banks PB: Interacting effects of predation risk and signal patchiness on activity and communication in house mice. J Anim Ecol 2010;79:88-97.
13.
Boedeker E, Friedel G, Walles T: Sniffer dogs as part of a bimodal bionic research approach to develop a lung cancer screening. Interact Cardiovasc Thorac Surg 2012;14:511-515.
14.
Domjan M: The Principles of Learning and Behavior. Canada, Cengage Learning, 2009.
15.
Palermo-Neto J, Fonseca ES, Quinteiro-Filho WM, Correia CS, Sakai M: Effects of individual housing on behavior and resistance to Ehrlich tumor growth in mice. Physiol Behav 2008;95:435-440.
16.
Wenk GL: Assessment of spatial memory using the T maze. Curr Protoc Neurosci 2001, DOI: 10.1002/0471142301.
17.
Kirsten TB, Taricano M, Maiorka PC, Palermo-Neto J, Bernardi MM: Prenatal lipopolysaccharide reduces social behavior in male offspring. Neuroimmunomodulation 2010;17:240-251.
18.
Marana E, Russo A, Colicci S, Polidori L, Bevilacqua F, Viviani D, Di Stasio E: Desflurane versus sevoflurane: a comparison on stress response. Minerva Anestesiol 2013;79:7-14.
19.
Hasui M, Hirabayashi Y, Kobayashi Y: Simultaneous measurement by flow cytometry of phagocytosis and hydrogen peroxide production of neutrophils in whole blood. J Immunol Methods 1989;117:53-58.
20.
Dantzer R: Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur J Pharmacol 2004;500:399-411.
21.
File SE, Seth P: A review of 25 years of the social interaction test. Eur J Pharmacol 2003;463:35-53.
22.
Niesink RJ, van Ree JM: Short-term isolation increases social interactions of male rats: a parametric analysis. Physiol Behav 1982;29:819-825.
23.
Venzala E, García-García AL, Elizalde N, Tordera RM: Social vs. environmental stress model of depression from a behavioral and neurochemical approach. Eur Neuropsychopharmacol 2013;23:697-708.
24.
Glavin G, Tanaka A, Tsuda Y, Hoaki Y, Nagasaki HN: Regional rat brain noradrenaline turnover in response to restraint stress. Pharmacol Biochem Behav 1983;19:287-290.
25.
Glavin GB: Stress and brain noradrenaline: a review. Neurosci Biobehav Rev 1985;9:233-243.
26.
Hayley S, Borowski T, Merali Z, Anisman H: Central monoamine activity in genetically distinct strains of mice following a psychogenic stressor: effects of predator exposure. Brain Res 2001;892:293-300.
27.
Armario A, Daviu N, Muñoz-Abellán C, Rabasa C, Fuentes S, Belda X, Gagliano H, Nadal R: What can we know from pituitary-adrenal hormones about the nature and consequences of exposure to emotional stressors? Cell Mol Neurobiol 2012;32:749-758.
28.
Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES: The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000;52:595-638.
29.
Kohm AP, Sanders VM: Norepinephrine. A messenger from the brain to the immune system. Immunol Today 2000;21:539-542.
30.
Arakawa H, Blanchard DC, Arakawa K, Dunlap C, Blanchard RJ: Scent marking behavior as an odorant communication in mice. Neurosci Biobehav Rev 2008;32:1236-1248.
31.
Carr WJ, Martorano RD, Krames L: Responses of mice to odors associated with stress. J Comp Physiol Psychol 1970;71:223-228.
32.
Arakawa H, Arakawa K, Blanchard DC, Blanchard RJ: A new test paradigm for social recognition evidenced by urinary scent marking behavior in C57BL/6J mice. Behav Brain Res 2008;190:97-104.
33.
Arakawa H, Arakawa K, Blanchard DC, Blanchard RJ: Social features of scent-donor mice modulate scent marking of C57BL/6J recipient males. Behav Brain Res 2009;205:138-145.
34.
Kavaliers M, Colwell DD: Discrimination by female mice between the odours of parasitized and non-parasitized males. Proc Biol Sci 1995;261:31-35.
35.
Alves GJ, Vismari L, Palermo-Neto J: Cohabitation with a sick cage mate: effects on ascitic form of Ehrlich tumor growth and macrophage activity. Neuroimmunomodulation 2007;14:297-303.
36.
Palermo-Neto J, Fonseca ESM, Quinteiro-Filho WM, Correia CSC, Sakai M: Effects of individual housing on behavior and resistance to Ehrlich tumor growth in mice. Physio Behav 2008;95:435-440.
37.
Klimp AH, Vries EG, Scherphof GL, Daemen T: A potential macrophage activation in the treatment of cancer. Crit Rev Oncol Hematol 2002;44: 143-161.
38.
Matsumura K, Opiekun M, Oka H, Vachani A, Albelda SM, Yamazaki K, Beauchamp GK: Urinary volatile compounds as biomarkers for lung cancer: A proof of principle study using odor signatures in mouse models of lung cancer. PLoS One. 2010;5:e8819.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.